Literature DB >> 26252618

Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.

Ute I Scholl1,2, James M Healy3, Anne Thiel2, Annabelle L Fonseca3, Taylor C Brown3, John W Kunstman3, Matthew J Horne4, Dimo Dietrich5, Jasmin Riemer6, Seher Kücükköylü2, Esther N Reimer2, Anna-Carinna Reis7, Gerald Goh1, Glen Kristiansen5, Amit Mahajan8, Reju Korah3, Richard P Lifton1, Manju L Prasad4, Tobias Carling3.   

Abstract

UNLABELLED: Aldosterone-producing adenomas (APAs) and bilateral adrenal hyperplasia are important causes of secondary hypertension. Somatic mutations in KCNJ5, CACNA1D, ATP1A1, ATP2B3 and CTNNB1 have been described in APAs.
OBJECTIVE: To characterize clinical-pathological features in APAs and unilateral adrenal hyperplasia, and correlate them with genotypes.
DESIGN: Retrospective study. SUBJECTS AND MEASUREMENTS: Clinical and pathological characteristics of 90 APAs and seven diffusely or focally hyperplastic adrenal glands were reviewed, and samples were examined for mutations in known disease genes by Sanger or exome sequencing.
RESULTS: Mutation frequencies were as follows: KCNJ5, 37·1%; CACNA1D, 10·3%; ATP1A1, 8·2%; ATP2B3, 3·1%; and CTNNB1, 2·1%. Previously unidentified mutations included I157K, F154C and two insertions (I150_G151insM and I144_E145insAI) in KCNJ5, all close to the selectivity filter, V426G_V427Q_A428_L433del in ATP2B3 and A39Efs*3 in CTNNB1. Mutations in KCNJ5 were associated with female and other mutations with male gender (P = 0·007). On computed tomography, KCNJ5-mutant tumours displayed significantly greater diameter (P = 0·023), calculated area (P = 0·002) and lower precontrast Hounsfield units (P = 0·0002) vs tumours with mutations in other genes. Accordingly, KCNJ5-mutant tumours were predominantly comprised of lipid-rich fasciculata-like clear cells, whereas other tumours were heterogeneous (P = 5 × 10(-6) vs non-KCNJ5 mutant and P = 0·0003 vs wild-type tumours, respectively). CACNA1D mutations were present in two samples with hyperplasia without adenoma.
CONCLUSIONS: KCNJ5-mutant tumours appear to be associated with fasciculata-like clear cell predominant histology and tend to be larger with a characteristic imaging phenotype. Novel somatic KCNJ5 variants likely cause adenomas by loss of potassium selectivity, similar to previously described mutations.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26252618      PMCID: PMC4995792          DOI: 10.1111/cen.12873

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  35 in total

1.  Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Authors:  Sheerazed Boulkroun; Felix Beuschlein; Gian-Paolo Rossi; José-Felipe Golib-Dzib; Evelyn Fischer; Laurence Amar; Paolo Mulatero; Benoit Samson-Couterie; Stefanie Hahner; Marcus Quinkler; Francesco Fallo; Claudio Letizia; Bruno Allolio; Giulio Ceolotto; Maria Verena Cicala; Katharina Lang; Hervé Lefebvre; Livia Lenzini; Carmela Maniero; Silvia Monticone; Maelle Perrocheau; Catia Pilon; Pierre-François Plouin; Nada Rayes; Teresa M Seccia; Franco Veglio; Tracy Ann Williams; Laura Zinnamosca; Franco Mantero; Arndt Benecke; Xavier Jeunemaitre; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

2.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Authors:  Felix Beuschlein; Sheerazed Boulkroun; Andrea Osswald; Thomas Wieland; Hang N Nielsen; Urs D Lichtenauer; David Penton; Vivien R Schack; Laurence Amar; Evelyn Fischer; Anett Walther; Philipp Tauber; Thomas Schwarzmayr; Susanne Diener; Elisabeth Graf; Bruno Allolio; Benoit Samson-Couterie; Arndt Benecke; Marcus Quinkler; Francesco Fallo; Pierre-Francois Plouin; Franco Mantero; Thomas Meitinger; Paolo Mulatero; Xavier Jeunemaitre; Richard Warth; Bente Vilsen; Maria-Christina Zennaro; Tim M Strom; Martin Reincke
Journal:  Nat Genet       Date:  2013-02-17       Impact factor: 38.330

Review 3.  Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review.

Authors:  O Steichen; F Zinzindohoué; P-F Plouin; L Amar
Journal:  Horm Metab Res       Date:  2012-01-13       Impact factor: 2.936

4.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

5.  Adrenal venous sampling: evaluation of the German Conn's registry.

Authors:  Oliver Vonend; Nora Ockenfels; Xing Gao; Bruno Allolio; Katharina Lang; Knut Mai; Ivo Quack; Andreas Saleh; Christoph Degenhart; Jochen Seufert; Lysann Seiler; Felix Beuschlein; Marcus Quinkler; Petr Podrabsky; Martin Bidlingmaier; Reinhard Lorenz; Martin Reincke; Lars Christian Rump
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

Review 7.  New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.

Authors:  Ute I Scholl; Richard P Lifton
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

8.  Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.

Authors:  Baojun Wang; Xintao Li; Xu Zhang; Xin Ma; Luyao Chen; Yu Zhang; Xiangjun Lyu; Yuzhe Tang; Qingbo Huang; Yu Gao; Yang Fan; Jinzhi Ouyang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

9.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

10.  Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.

Authors:  Tobias Åkerström; Joakim Crona; Alberto Delgado Verdugo; Lee F Starker; Kenko Cupisti; Holger S Willenberg; Wolfram T Knoefel; Wolfgang Saeger; Alfred Feller; Julian Ip; Patsy Soon; Martin Anlauf; Pier F Alesina; Kurt W Schmid; Myriam Decaussin; Pierre Levillain; Bo Wängberg; Jean-Louis Peix; Bruce Robinson; Jan Zedenius; Martin Bäckdahl; Stefano Caramuta; K Alexander Iwen; Johan Botling; Peter Stålberg; Jean-Louis Kraimps; Henning Dralle; Per Hellman; Stan Sidhu; Gunnar Westin; Hendrik Lehnert; Martin K Walz; Göran Åkerström; Tobias Carling; Murim Choi; Richard P Lifton; Peyman Björklund
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  41 in total

1.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  Familial hyperaldosteronism type III a novel case and review of literature.

Authors:  Natividad Pons Fernández; Francisca Moreno; Julia Morata; Ana Moriano; Sara León; Carmen De Mingo; Ángel Zuñiga; Fernando Calvo
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 3.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 4.  [Primary aldosteronism : Genetics and pathology].

Authors:  U Scholl
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

5.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 6.  Aldosterone-Producing Cell Clusters in Normal and Pathological States.

Authors:  Kei Omata; Scott A Tomlins; William E Rainey
Journal:  Horm Metab Res       Date:  2017-12-04       Impact factor: 2.936

Review 7.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

8.  Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Authors:  Yuto Yamazaki; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yuzu Adachi; Kazue Ise; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Yukiko Shibahara; Takumi Kitamoto; Tetsuo Nishikawa; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

9.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

10.  KCNK3 Variants Are Associated With Hyperaldosteronism and Hypertension.

Authors:  Ani Manichaikul; Stephen S Rich; Matthew A Allison; Nick A Guagliardo; Douglas A Bayliss; Robert M Carey; Paula Q Barrett
Journal:  Hypertension       Date:  2016-06-13       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.